SNYR Stock Forecast & Price Target

Synergy CHC Corp reported net revenues of $8.0 million in 3Q'24, reflecting a 12% increase from the previous year, despite being 27% below the company’s internal estimate. The growth in revenue was primarily driven by a shift towards higher margin supplement sales, with gross margins recorded at 67.2%, slightly lower than anticipated. With expectations of significant advancements in sales, product development, and expanded retail partnerships, the company is poised for improved visibility into future profits, cash flows, and overall shareholder value.

Synergy CHC Corp has experienced a concerning stagnation in Adjusted EBITDA, totaling $1.3 million, which falls short of expectations due to lower revenue and tight cash flow conditions prior to a recent equity raise. The company is facing declining revenue estimates for 2025, 2026, and 2027, with figures revised downwards to $35.4 million, $54.2 million, and $60.6 million respectively, indicating an overall deterioration in financial outlook. Furthermore, the company's share price has shown significant weakness and volatility over the past year, compounded by an anticipated decline in consumer spending amid unfavorable economic conditions.